MedPath

A prospective study to evaluate the efficacy of proactive management in infantile atopic dermatitis for prevention of sensitization to house dust mite and atopic march

Not Applicable
Recruiting
Conditions
atopic dermatitis
Registration Number
JPRN-UMIN000006876
Lead Sponsor
Department of Pediatrics, Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria is as followed; (1) The patients receiving any additional systemic therapies included corticosteroids, nonsteroidal immunosuppressive agents or biological immunotherapy, (2) the patients who has a past history of cardiovascular disease, liver dysfunction, kidney disease and other current serious medical problems.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
House dust mite specific IgE and house dust mite specific lymphocyte stimulation test [Time Frame: 24 months]
Secondary Outcome Measures
NameTimeMethod
Japanese cedar pollen specific IgE and specific lymphocyte stimulation test [Time Frame: 24 months]
© Copyright 2025. All Rights Reserved by MedPath